Inspections, Compliance, Enforcement, and Criminal Investigations
Golden-State Medical Supply, Inc. - Close Out Letter 4/19/12
| Public Health Service Food and Drug Administration |
Los Angeles District |
VIA UNITED PARCEL SERVICE
SIGNATURE REQUIRED
April 19, 2012
James L. Stroud, Chief Executive Officer
Golden-State Medical Supply, Inc.
5187 Camino Ruiz
Camarillo, California 93012-8601
Dear Mr. Stroud:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (WL #35-11 dated April 26, 2011). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these
corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Alonza E. Cruse
Los Angeles District





Department of Health and Human Services

